Literature DB >> 11754960

Bioactivity of adrenomedullin and proadrenomedullin N-terminal 20 peptide in man.

M G Nicholls1, J G Lainchbury, L K Lewis, D O McGregor, A M Richards, R W Troughton, T G Yandle.   

Abstract

Although the biological effects of adrenomedullin (AM) and PAMP have been reported extensively in animal studies and from in-vitro experiments, relatively little information is available on responses to the hormone administered to man. This review summarizes data from the few studies carried out in man. In healthy volunteers, i.v. infusion of AM reduces arterial pressure, probably at a lower rate of administration than is required to elicit other responses. AM stimulates heart rate, cardiac output, plasma levels of cAMP, prolactin, norepinephrine and renin whilst inhibiting any concomitant response in plasma aldosterone. Little or no increase in urine volume or sodium excretion has been observed. Patients with essential hypertension differ only in showing a greater fall in arterial pressure and in the development of facial flushing and headache. In patients with heart failure or chronic renal failure, i.v. AM has similar effects to those seen in normal subjects but also induces a diuresis and natriuresis, depending on the dose administered. Infusion of AM into the brachial artery results in a dose-related increase in forearm and skin blood flow, more prominent and more dependent on endogenous nitric oxide in healthy volunteers than in patients with cardiac failure. When infused into a dorsal hand vein, AM partially reversed the venoconstrictor action of norepinephrine. Although much more information is required to clarify the role of AM under physiological and pathophysiological circumstances, it is clear that it has prominent hemodynamic and neurohormonal effects, though generally lesser urinary effects when administered short-term in doses sufficient to raise its levels in plasma to those seen in a number of clinical disorders. The only study of PAMP in man showed that its skeletal muscle vasodilator potency, when infused into the brachial artery of healthy volunteers, was less than one hundredth that of AM, and it was without effect on skin blood flow.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11754960     DOI: 10.1016/s0196-9781(01)00508-3

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  5 in total

1.  Urocortin and adrenomedullin prevent lethal endotoxemia by down-regulating the inflammatory response.

Authors:  Elena Gonzalez-Rey; Alejo Chorny; Nieves Varela; Gema Robledo; Mario Delgado
Journal:  Am J Pathol       Date:  2006-06       Impact factor: 4.307

Review 2.  Flushing Disorders Associated with Gastrointestinal Symptoms: Part 1, Neuroendocrine Tumors, Mast Cell Disorders and Hyperbasophila.

Authors:  Vaibhav Rastogi; Devina Singh; Joseph J Mazza; Dipendra Parajuli; Steven H Yale
Journal:  Clin Med Res       Date:  2018-04-12

Review 3.  Flushing in (neuro)endocrinology.

Authors:  Fady Hannah-Shmouni; Constantine A Stratakis; Christian A Koch
Journal:  Rev Endocr Metab Disord       Date:  2016-09       Impact factor: 6.514

4.  Adrenomedullin and endothelin-1 are associated with myocardial injury and death in septic shock patients.

Authors:  Oscar H M Lundberg; Lill Bergenzaun; Jörgen Rydén; Mari Rosenqvist; Olle Melander; Michelle S Chew
Journal:  Crit Care       Date:  2016-06-09       Impact factor: 9.097

5.  Circulating bioactive adrenomedullin as a marker of sepsis, septic shock and critical illness.

Authors:  Oscar H M Lundberg; Maria Lengquist; Martin Spångfors; Martin Annborn; Deborah Bergmann; Janin Schulte; Helena Levin; Olle Melander; Attila Frigyesi; Hans Friberg
Journal:  Crit Care       Date:  2020-11-04       Impact factor: 9.097

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.